$辉瑞(PFE)$ C.Q. Pharmaceutical'_老虎社区_美港股上老虎

$辉瑞(PFE)$ C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":509621449195952,"tweetId":"509621449195952","gmtCreate":1765457240738,"gmtModify":1765457242969,"author":{"id":4136426194875310,"idStr":"4136426194875310","authorId":4136426194875310,"authorIdStr":"4136426194875310","name":"天蓝色的市场","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.</p></body></html>","text":"$辉瑞(PFE)$ C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/509621449195952","repostId":0,"isVote":1,"tweetType":1,"viewCount":502,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":286,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/509621449195952"}